TY - JOUR

T1 - Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis

AU - Sandoo, A.A.

AU - Kitas, G.

AU - Dimitroulas, T.

AU - Sandoo, A.

AU - Smith, J.P.

AU - Kitas, G.D.

PY - 2014/1/10

Y1 - 2014/1/10

N2 - Rheumatoid Arthritis (RA) is associated with increased cardiovascular (CV) mortality and reduced life expectancy predominantly due to increased rates of acute coronary syndromes including unrecognized myocardial infractions [1]. The increased CV burden in this population has prompted rheumatologists and cardiologists to a more early and vigilant screening for CV risk stratification even in asymptomatic patients. Asymmetric dimethylarginine (ADMA) and subendocardial viability ratio (SEVR) represent non-invasive methods of assessing endothelial dysfunction and coronary microvascular perfusion to subendocardium respectively, two pivotal players in the development of CV disease and myocardial ischemia

AB - Rheumatoid Arthritis (RA) is associated with increased cardiovascular (CV) mortality and reduced life expectancy predominantly due to increased rates of acute coronary syndromes including unrecognized myocardial infractions [1]. The increased CV burden in this population has prompted rheumatologists and cardiologists to a more early and vigilant screening for CV risk stratification even in asymptomatic patients. Asymmetric dimethylarginine (ADMA) and subendocardial viability ratio (SEVR) represent non-invasive methods of assessing endothelial dysfunction and coronary microvascular perfusion to subendocardium respectively, two pivotal players in the development of CV disease and myocardial ischemia

U2 - 10.1016/j.ijcard.2013.12.235

DO - 10.1016/j.ijcard.2013.12.235

M3 - Article

VL - 172

SP - 285

EP - 286

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 1

ER -